Research Roundup

Debbie Rigby rounds up the latest in research news Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community Interim analyses from the PRINCIPLE trial shows that inhaled budesonide reduces time to recovery by a median of 3 days in people with COVID-19 with risk factors for adverse outcomes. Participants